Mealey's Toxic Tort/Environmental - Pa. Supreme Court Vacates $27.7M Drug-Pricing Judgment Against Bristol-Myers

Mealey's Toxic Tort/Environmental - Pa. Supreme Court Vacates $27.7M Drug-Pricing Judgment Against Bristol-Myers

HARRISBURG, Pa. - The Pennsylvania Supreme Court on June 16 vacated a $27.7 million drug-pricing judgment against drug maker Bristol-Myers Squibb Co. (BMS) because a trial court failed to account for billions of dollars in drug rebates paid to the state government (Commonwealth of Pennsylvania v. TAP Pharmaceutical Products, et al., No. 85 MAP 2011, Pa. Sup.).

Find full version on lexis Advance®
Access this news story on lexis.com®